Billions Spent on DMD Meds Despite Scant Proof of Efficacy Billions Spent on DMD Meds Despite Scant Proof of Efficacy

Over 7 years, the US health care system spent more than $3 billion on DMD treatments eteplirsen, golodirsen, and casimersen, despite a lack of confirmatory trial data.Medscape Medical News
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Neurology & Neurosurgery Source Type: news